These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 23188068

  • 1. The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).
    Lewis LD, Miller AA, Owzar K, Bies RR, Markova S, Jiang C, Kroetz DL, Egorin MJ, McLeod HL, Ratain MJ, Alliance for Clinical Trials in Oncology.
    Pharmacogenet Genomics; 2013 Jan; 23(1):29-33. PubMed ID: 23188068
    [Abstract] [Full Text] [Related]

  • 2. Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia.
    Kiyotani K, Mushiroda T, Kubo M, Zembutsu H, Sugiyama Y, Nakamura Y.
    Cancer Sci; 2008 May; 99(5):967-72. PubMed ID: 18294295
    [Abstract] [Full Text] [Related]

  • 3. Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.
    Chew SC, Sandanaraj E, Singh O, Chen X, Tan EH, Lim WT, Lee EJ, Chowbay B.
    Br J Clin Pharmacol; 2012 Apr; 73(4):606-18. PubMed ID: 21995462
    [Abstract] [Full Text] [Related]

  • 4. The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
    Chew SC, Singh O, Chen X, Ramasamy RD, Kulkarni T, Lee EJ, Tan EH, Lim WT, Chowbay B.
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1471-8. PubMed ID: 21468756
    [Abstract] [Full Text] [Related]

  • 5. Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
    Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Suzuki T, Habuchi T.
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1161-9. PubMed ID: 17906856
    [Abstract] [Full Text] [Related]

  • 6. Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy.
    Kim KP, Ahn JH, Kim SB, Jung KH, Yoon DH, Lee JS, Ahn SH.
    Cancer Chemother Pharmacol; 2012 May; 69(5):1221-7. PubMed ID: 22271208
    [Abstract] [Full Text] [Related]

  • 7. Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.
    Nieuweboer AJ, Smid M, de Graan AM, Elbouazzaoui S, de Bruijn P, Eskens FA, Hamberg P, Martens JW, Sparreboom A, de Wit R, van Schaik RH, Mathijssen RH.
    Pharmacogenomics J; 2016 Nov; 16(6):519-524. PubMed ID: 26345519
    [Abstract] [Full Text] [Related]

  • 8. Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.
    Endo S, Fukahori A, Tokuhiro S, Shinagawa A, Walker J, Yoshihara K, Ishizuka H, Ieiri I, Sugiyama Y.
    J Hum Genet; 2012 Aug; 57(8):531-44. PubMed ID: 22695893
    [Abstract] [Full Text] [Related]

  • 9. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.
    Geng F, Jiao Z, Dao YJ, Qiu XY, Ding JJ, Shi XJ, Li ZD, Zhong MK.
    Clin Chim Acta; 2012 Apr 11; 413(7-8):683-90. PubMed ID: 22227166
    [Abstract] [Full Text] [Related]

  • 10. Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort.
    Sone K, Oguri T, Uemura T, Takeuchi A, Fukuda S, Takakuwa O, Maeno K, Fukumitsu K, Kanemitsu Y, Ohkubo H, Takemura M, Ito Y, Niimi A.
    BMC Cancer; 2019 Mar 19; 19(1):246. PubMed ID: 30890141
    [Abstract] [Full Text] [Related]

  • 11. Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
    de Graan AJ, Lancaster CS, Obaidat A, Hagenbuch B, Elens L, Friberg LE, de Bruijn P, Hu S, Gibson AA, Bruun GH, Corydon TJ, Mikkelsen TS, Walker AL, Du G, Loos WJ, van Schaik RH, Baker SD, Mathijssen RH, Sparreboom A.
    Clin Cancer Res; 2012 Aug 15; 18(16):4433-40. PubMed ID: 22711709
    [Abstract] [Full Text] [Related]

  • 12. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
    Lee HH, Leake BF, Teft W, Tirona RG, Kim RB, Ho RH.
    Mol Cancer Ther; 2015 Apr 15; 14(4):994-1003. PubMed ID: 25695959
    [Abstract] [Full Text] [Related]

  • 13. ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
    Nomura H, Tsuji D, Demachi K, Mochizuki N, Matsuzawa H, Yano T, Daiko H, Fujii S, Kojima T, Itoh K, Kawasaki T.
    Cancer Chemother Pharmacol; 2020 Aug 15; 86(2):315-324. PubMed ID: 32748110
    [Abstract] [Full Text] [Related]

  • 14. Loss of SLCO1B3 drives taxane resistance in prostate cancer.
    de Morrée ES, Böttcher R, van Soest RJ, Aghai A, de Ridder CM, Gibson AA, Mathijssen RH, Burger H, Wiemer EA, Sparreboom A, de Wit R, van Weerden WM.
    Br J Cancer; 2016 Sep 06; 115(6):674-81. PubMed ID: 27537383
    [Abstract] [Full Text] [Related]

  • 15. Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia.
    Yamakawa Y, Hamada A, Nakashima R, Yuki M, Hirayama C, Kawaguchi T, Saito H.
    Ther Drug Monit; 2011 Apr 06; 33(2):244-50. PubMed ID: 21311410
    [Abstract] [Full Text] [Related]

  • 16. Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer.
    Franke RM, Carducci MA, Rudek MA, Baker SD, Sparreboom A.
    J Clin Oncol; 2010 Oct 20; 28(30):4562-7. PubMed ID: 20855838
    [Abstract] [Full Text] [Related]

  • 17. Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
    Jabir RS, Ho GF, Annuar MABA, Stanslas J.
    Clin Breast Cancer; 2018 Oct 20; 18(5):e1173-e1179. PubMed ID: 29885788
    [Abstract] [Full Text] [Related]

  • 18. Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.
    de Lima LT, Bueno CT, Vivona D, Hirata RD, Hirata MH, Hungria VT, Chiattone CS, Zanichelli MA, Chauffaille Mde L, Guerra-Shinohara EM.
    Hematology; 2015 Apr 20; 20(3):137-42. PubMed ID: 25056761
    [Abstract] [Full Text] [Related]

  • 19. Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.
    Jabir RS, Naidu R, Annuar MA, Ho GF, Munisamy M, Stanslas J.
    Pharmacogenomics; 2012 Dec 20; 13(16):1979-88. PubMed ID: 23215890
    [Abstract] [Full Text] [Related]

  • 20. Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension
.
    Pei Q, Yang L, Tan HY, Liu SK, Liu Y, Huang L, Li RH, Wan Q, Huang J, Guo CX, Zuo XC, Li J, Yang GP.
    Int J Clin Pharmacol Ther; 2017 Aug 20; 55(8):659-665. PubMed ID: 28518053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.